These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1650194)
21. Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside. Balzarini J; Naesens L; Robins MJ; De Clercq E J Acquir Immune Defic Syndr (1988); 1990; 3(12):1140-7. PubMed ID: 2123003 [TBL] [Abstract][Full Text] [Related]
22. Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro. Koff WC; Elm JL; Halstead SB Antiviral Res; 1982 May; 2(1-2):69-79. PubMed ID: 7201778 [TBL] [Abstract][Full Text] [Related]
23. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin. Murphy MF J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625 [TBL] [Abstract][Full Text] [Related]
24. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1. Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of lymphocyte proliferative responses by ribavirin. Peavy DL; Koff WC; Hyman DS; Knight V Infect Immun; 1980 Aug; 29(2):583-9. PubMed ID: 7216427 [TBL] [Abstract][Full Text] [Related]
37. Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine. Ahluwalia G; Cooney DA; Hartman NR; Mitsuya H; Yarchoan R; Fridland A; Broder S; Johns DG Drug Metab Dispos; 1993; 21(2):369-76. PubMed ID: 8097711 [TBL] [Abstract][Full Text] [Related]
38. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Huggins JW; Robins RK; Canonico PG Antimicrob Agents Chemother; 1984 Oct; 26(4):476-80. PubMed ID: 6151377 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents. Okano Y; Saito-Tarashima N; Kurosawa M; Iwabu A; Ota M; Watanabe T; Kato F; Hishiki T; Fujimuro M; Minakawa N Bioorg Med Chem; 2019 Jun; 27(11):2181-2186. PubMed ID: 31003866 [TBL] [Abstract][Full Text] [Related]
40. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate. Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]